Drug Class
HIF-2 alpha inhibitor
Type
brand
Active Ingredient
belzutifan
📋Overview
Welireg is a medication that targets specific proteins involved in the growth of certain tumors. It is primarily associated with the treatment of cancers related to genetic conditions that affect oxygen sensing in cells, such as von Hippel-Lindau (VHL) disease. By inhibiting these proteins, Welireg can help slow the progression of tumors in affected individuals. Its use is focused on rare hereditary cancer syndromes.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Welireg
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.